Integrating Genomics and Proteomics to Identify Causal Proteins and Biologic Pathways for Incident Atrial Fibrillation in CKD
Journal of the American Society of Nephrology · 2026
DOI: 10.1681/asn.0000001117 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, 2026. Verfasst von Adrian M Petzl und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Atrial Fibrillation, Proteomics, Renal Insufficiency, Chronic, Genomics. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NCRR NIH HHS, ARPA-H program.
Abstract (Originalsprache)
Key Points Using proteomics and Mendelian randomization, we identified causal proteins for the development of atrial fibrillation in patients with CKD. Immunologic function, cell growth, and neural development were common biologic pathways underlying atrial fibrillation and left atrial enlargement. Machine learning led to a nine-protein risk model that had a similar predictive performance for incident atrial fibrillation as clinical risk scores.
Background
CKD is strongly associated with atrial fibrillation. Understanding the biologic pathways for this association and creating predictive models have been challenging. Left atrial enlargement is a substrate for atrial fibrillation, but any overlap between biomarkers of atrial fibrillation and left atrial enlargement in patients with CKD is unknown.
Methods
We evaluated 4590 plasma proteins with SomaScan in two cohorts of adult patients with CKD: the Chronic Renal Insufficiency Cohort (CRIC; n =2654) and the Atherosclerosis Risk in Communities cohort (ARIC; n =1326). Using Mendelian randomization, we identified proteins along the causal pathway to atrial fibrillation. We also identified proteins and corresponding pathways associated with larger echocardiographic left atrial size, a recognized substrate for atrial fibrillation. Finally, we developed and validated a multiprotein risk score for incident atrial fibrillation in the CKD population.
Results
Over 5 years, incident atrial fibrillation occurred among 150 patients in the CRIC and 140 in the ARIC cohort. We identified three proteins causally linked to incident atrial fibrillation: neural EGF like‑like protein 1, cartilage intermediate layer protein 2, and matrix metallopeptidase 12. Pathway analysis revealed an overlap in eight of the top ten canonical pathways for incident atrial fibrillation and left atrial enlargement. A risk model for incident atrial fibrillation composed of proteins had annualized areas under the receiver-operating characteristic curve over 5 years ranging from 0.65 to 0.76, a performance similar to the Cohorts for Heart and Aging Research in Genomic Epidemiology Atrial Fibrillation (CHARGE-AF) clinical risk score.
Conclusions
This study identified causal proteins and biologic mechanisms underlying incident atrial fibrillation in CKD. A proteomic risk score for incident atrial fibrillation in CKD performed similarly to the CHARGE-AF clinical risk score.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
- Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
- Division of Epidemiology and Community Health, University of Minnesota, Minneapolis, Minnesota.
- Department of Biostatistics, Harvard University, Cambridge, Massachusetts.
- Department of Medicine, University of Texas Southwestern Medical Center, Dallas, Texas.
- Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California.
ORCID-Profile: Adrian M Petzl, Yue Ren, Faye L Norby, Ruth F Dubin, Mark R Segal, Alvaro Alonso, Eugene P Rhee, Nisha Bansal, Ramachandran S Vasan, Aditya Surapaneni, Morgan E Grams, Harold Feldman, Francis E Marchlinski, Alan S Go, Hongzhe Lee, Peter Ganz, Rajat Deo
Förderung
- NIDDK NIH HHS
- NCRR NIH HHS
- ARPA-H program
- NHLBI NIH HHS
- NCATS NIH HHS
- NIGMS NIH HHS
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Heart, Lung, and Blood Institute
Zitieren
APA
Petzl, A. M., Ren, Y., Norby, F. L., Wang, J., Dubin, R. F., Antanavicius, I., Segal, M. R., Chen, L. Y., Alonso, A., Rhee, E. P., Bansal, N., Kimmel, P. L., Vasan, R. S., Surapaneni, A., Grams, M. E., Feldman, H., Marchlinski, F. E., Go, A. S., Lee, H., …, & Deo, R. (2026). Integrating Genomics and Proteomics to Identify Causal Proteins and Biologic Pathways for Incident Atrial Fibrillation in CKD. Journal of the American Society of Nephrology. https://doi.org/10.1681/asn.0000001117
Vancouver
Petzl AM, Ren Y, Norby FL, Wang J, Dubin RF, Antanavicius I, et al. Integrating Genomics and Proteomics to Identify Causal Proteins and Biologic Pathways for Incident Atrial Fibrillation in CKD. Journal of the American Society of Nephrology. 2026. doi:10.1681/asn.0000001117
BibTeX
@article{Petzl2026,
author = {Petzl, Adrian M and Ren, Yue and Norby, Faye L and Wang, Jianqiao and Dubin, Ruth F and Antanavicius, Izabele and Segal, Mark R and Chen, Lin Yee and Alonso, Alvaro and Rhee, Eugene P and Bansal, Nisha and Kimmel, Paul L and Vasan, Ramachandran S and Surapaneni, Aditya and Grams, Morgan E and Feldman, Harold and Marchlinski, Francis E and Go, Alan S and Lee, Hongzhe and Ganz, Peter and Deo, Rajat},
title = {Integrating Genomics and Proteomics to Identify Causal Proteins and Biologic Pathways for Incident Atrial Fibrillation in CKD},
journal = {Journal of the American Society of Nephrology},
year = {2026},
doi = {10.1681/asn.0000001117}
}
EUVIMED